is the direct target of the RA receptor-retinoid X receptor heterodimer; and (ii) a motif for an RA-inducible and tissuespecific coactivator termed retinoid-inducible protein.
Though neither enhancer alone is functional, this combined element strongly activates the HOXB1 promoter in a cellspecific and retinoid-dependent manner. Finally, this activation is potentiated by a proximal autoregulatory site for HOXB1 gene itself. These data define a tripartite cascade leading to the establishment of HOXB1 gene activation.
The mammalian homeobox genes (HOX) encode a family of >30 related proteins that share the common "homeo box" motif originally identified in Drosophila Antennapedial Bithorax homeotic complex (1) . Human homeobox gene clusters designated HOX A, B, C, and D were mapped on chromosomes 7, 17, 12, and 2, respectively, and retain a linear gene arrangement similar to their Drosophila counterparts (2) . Expression of mammalian homeobox genes is strictly regulated temporally and spatially during embryonic development (3) (4) (5) . Strikingly, it has been shown that the position of mammalian and Drosophila homeobox genes in each cluster follows the order of the anterior boundaries of their expression along the anterior-posterior axis of the developing embryo (6, 7) .
Retinoic acid (RA), a natural metabolite of vitamin A, has been proposed to be a vertebrate morphogen and a regulator of the HOX gene clusters (8, 9) . Systemic treatment of vertebrate embryos with RA results in severe developmental deformities, whereas local application of RA to the chicken limb bud produces digit duplication that is accompanied by a change of homeobox gene expression (10) (11) (12) .
In the human embryonal carcinoma cell line NT2/D1 (13) , homeobox genes are sequentially activated by RA in a graded fashion from the 3' -> 5' direction (14) . Activation of the 3' HOXB1 gene is not dependent on protein synthesis and thus is a candidate for direct regulation by RA (15) . However, the precise molecular link between HOXB1 and RA signaling and the mechanism establishing graded chromosomal expression remain obscure. The actions of RA are mediated by the RA receptors (RARs) and retinoid X receptors (RXRs), both members of the nuclear receptor family (16) (17) (18) (19) (20) (21) (22) . These receptors have been shown to function through a heterodimer to create a sequence-specific DNA binding complex that activates target genes through an RA-responsive element (RARE) in a hormone-dependent pathway. Mouse Hoxa-1 and Hoxb-1 genes are located at the 3' end of each cluster (labial paralogues) and have a similar pattern of expression in the posterior half of the 7.5-to 8.0-day mouse embryo (23) . It is important to note that both genes have been reported to have RAREs in the 3' regions (24, 25) . Our preliminary data suggest that this RARE is required for the establishment of early expression in the posterior half of the embryo. However, by day 8.5 of gestation, expression of the Hoxa-1 and Hoxb-1 genes has retreated caudally with the exception of the persistence of Hoxb-1 in rhombomere 4. As reported, this rhombomere 4-specific expression is sensitive to RA, a second RA signaling pathway for midgestational activation. We provide evidence for a 5' promoter proximal set of regulatory elements that controls HOXB1 gene expression in a cell-specific and retinoid-dependent manner.
MATERIALS AND METHODS Plasmids. A DNA fragment containing the thymidine kinase (TK) luciferase gene was ligated into the Sal I site in pBluescript SK (+) vector (Stratagene) using the Sal I linker (pBS.TK.Luc). TK promoter was replaced by various genomic DNA fragments derived from the 5' region of HOXB1 gene of human cosmid clone cwd3. DR-2A (5'-TCACTCCCT-GAACTCTTGCCCTCCTGGACT-3'), DR-2B (5'-CGG-GCTGACCTTTTTACCTCGAAGCG-3'), upstream response element (URE) (5'-CAGGCAGACACCCTGACAG-GTTACAAATGA GCGTGG-3'), and UREmut (5'-CAG-GCAGACACACTAGTAGGTTACAAATGAGCGTGG-3') oligonucleotides were used for the construction.
Cell Cultures and Transfection. Embryonal carcinoma cell lines P19 and NT2/D1 (13) were grown in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal bovine serum (Irvine Scientific). Twenty-four hours (1 hr for P19 cells) before transfection, cells were split in fresh medium described above. Transfection was performed by using the calcium phosphate precipitation method. Five micrograms of reporter luciferase plasmid and 7 gg of pCMX-f3GAL (as an internal control) were transfected. NT2/D1 and P19 cells were incubated for 12 hr in the presence of DNA precipitates. After DNA precipitates were washed, cells were cultured with fresh medium containing 1 ,uM RA for another 24 hr. Cells were harvested and the luciferase assays were carried out. Transfection efficiency was normalized by using ,B-galactosidase activity derived from pCMX-,BGAL.
Gel Retardation Assay. pCMX-hRARa and pCMXhRXRa were linearized, and capped mRNA was synthesized in vitro using T7 RNA polymerase (Stratagene) according to the manufacturer's instruction. Aliquots of mRNA were incubated with rabbit reticulocyte lysate (Promega) for in vitro translation. For gel retardation assay, 5 ,lI of in vitro translated proteins was preincubated in binding buffer [10 mM Tris, pH 8.0/40 mM KCl/0.05% Nonidet P-40/6% glycerol/1 mM dithiothreitol/5 ,ug of poly(dIldC) per ml] on ice for 15 min. For competition assays, a 20-fold molar excess of competitor oligonucleotides was mixed at this step. Oligonucleotides containing DR-5 (RARI32 RARE), HOXB DR-2A, and DR-2B were used as competitors and probes.
Abbreviations: RA, retinoic acid; RAR, RA receptor; RXR, retinoid X receptor; RARE, RA-responsive element; URE, upstream response element; RIP, retinoid-inducible protein; TK, thymidine kinase.
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RESULTS
To analyze the regulatory elements of the HOXB1 promoter, an overlapping set of large chromosomal fragments was isolated and ligated to a luciferase reporter gene. As shown in Fig.  1A , a 7-kb fragment spanning the HOXB1 promoter was transfected into two embryonal carcinoma cell lines: P19 (shaded bars) and NT2/D1 (solid bars). In P19 cells, but not in NT2/D1 cells, this plasmid was strongly induced by 1 ,uM RA. Reporter constructs containing either -2.0 kb or -1.6 kb of upstream sequence retained full enhancer activity, whereas deletions containing -1.2 kb or less produced only marginal induction. These data indicate the presence of a specific enhancer in an "400-bp region between Pst I and EcoRI restriction endonuclease sites (Fig. 1B) . This region was examined in more detail. RA activation was localized to a 160-nt Sac I-Hinfl subfragment that confers a 13-fold induction to RA (Fig. 1B) . Transfection experiments using a series of mutations within this small region and gel retardation assay revealed two candidate enhancer motifs in this region (Fig.  1C) : (i) a direct repeat of the sequence AGGTCA, which forms the core binding site for the RAR and the RXR and is observed in the antisense position (TGAACTctTGCCCT; designated DR-2A) and (ii) the URE, which serves as the binding site for RA-inducible cofactor RIP (retinoid-inducible piotein; see below).
The ability of RAR and RXR to form either homo-or heterodimers on the HOXB DR-2A and DR-2B (RARE found in the 3' side of HOXB1 gene) was examined by using a gel retardation assay. Human RARa and RXRa proteins were synthesized by in vitro translation using rabbit reticulocyte lysate and mixed with 32P-labeled response elements from the RARI32 RARE (a DR-5) and the HOXB DR-2A and DR-2B followed by gel electrophoresis. Fig. 2, lanes 1-4, 9-12) . Although the specific activities of the probes were the same, the DR-2 complex was less intense than the DR-5 band. This is in agreement with previous results suggesting that the RAR-RXR heterodimers may form lower affinity complexes on the DR-2 motif. These results indicate that RAR and RXR bind cooperatively to the DR-2A and DR-2B motifs as heterodimer.
Though the URE contains no homology to known RAREs, it is apparently necessary for RA response of the HOX reporter. The 160-bp Sac I-Hinfl fragment confers robust RA induction on HOXB1 promoter, whereas activation is severely repressed (to -25%) following mutation of the URE (Fig. ID,  constructs 1 and 2) . Removal of DR-2A sequence also severely repressed this activation (Fig. 1D, constructs 1, 3, and 4) . Interestingly, the URE and the RARE when tested independently as single copies show virtually no activity (data not shown). Even two tandem copies of the URE show only a low-level basal activity and are unresponsive to RA treatment (Fig. 3A) . Similarly, two copies of the DR-2A site show only modest RA responsiveness when tested in the absence of the URE. However, when combined, full retinoid inducibility is regained. This suggests that RA activation requires the costimulatory activity of the URE, the RARE, and their associated binding proteins.
Gel retardation analysis was used to identify the URE binding activity in nuclear extracts from P19 cells. In the absence of RA, only background level activity for binding to the URE-containing fragment is observed (Fig. 3B, lane 1) Fig. 1C (lane 4) . In contrast, no URE binding is seen in nuclear extracts from NT2/D1 cells either before or following RA treatment (lanes 5 and 6) . This would suggest that in these cells, the isolated HOX promoter would be unresponsive to RA induction. As shown in Fig. 1A , the HOX reporter is indeed unresponsive to RA, even in the presence of the URE and DR-2A (Fig. 1A, solid bars) . Interestingly, these cells are RA responsive as indicated by the control TK reporter containing the RAR,32 RARE (discussed below). Furthermore, the NT2/D1 cells are known to undergo differentiation in response to RA (13) . These results suggest that the deficiency of RIP precludes the HOX promoter from responding to RA. This is consistent with the results of Fig. 34 , indicating that the DR-2A site alone is incapable of producing a sustained RA response, and supports the suggestion that RA responsiveness of the HOXB1 promoter is based on a cooperative interaction with the URE and its associated binding protein (RIP). Thus, in this case, the RIP is functioning as an RA-dependent cofactor.
As is frequently observed, many genes encoding transcription factors like HOXB1 also contain binding sites for those transcription factors that would generate an autoregulatory loop for sustained activation. As shown in Fig. 44 , cotransfection of the series of reporter vectors along with a HOXBI expression vector identified significant inducibility, which mapped to a discrete promoter proximal region (Fig. 44, solid boxes) . Cotransfection of increasing amounts of CMX-HOXB1 expression vector produced up to a 20-fold activation (Fig. 44) Proc. NatL Acad ScL USA 92 (1995) the early somite stage, HOXB1 expression has become divided into the prospective rhombomere 4 domain and the posterior half of embryo (23, 27) . Teratogenic doses of RA induce the expansion of both domains of HOXB1. However, after the early somite stage, the rhombomere 4 expression becomes refractory to RA, whereas expression in the lateral foregut maintains its sensitivity (23, 27) . These lines of evidence strongly suggest that RA is one of important determinants controlling the expression of HOXB1 gene and that the sensitivity to RA may be regulated in a tissue-specific and time-specific manner. Preliminary data from transgenic mice harboring LacZ reporter gene controlled by the entire HOXB1 region strongly suggest that the RARE found in the promoter region is essential in the establishment of rhombomere 4 expression and regulation of its sensitivity to RA. Our in vitro data suggest a theoretical cascade to explain the establishment of rhombomere 4 expression. First, the RARRXR heterodimer is activated by endogenous retinoids, which, in turn, activate the coactivator RIP. Together, these proteins induce HOXB1 gene through the DR-2A element and the URE found in the promoter region. We have identified an autoregulatory site in the proximal region of the promoter that is strongly activated by the HOXB1-encoded protein. These data suggest that after the initial activation, expression is maintained by this autoregulatory loop, at which point the dependence and sensitivity of the HOXBJ gene to RA will be reduced or eliminated. This work provides the evidence for a complex but nonetheless central role of retinoid receptors in the activation and regulation of the HOXB1 gene. A key feature is the dependence on the highly inducible RIP gene, which is an actual component in the cascade. Accordingly, the purification and identification of RIP is anticipated to be essential in understanding the earliest events in HOX gene control.
